Magnetic resonance spectroscopy-guided transperineal prostate biopsy and brachytherapy for recurrent prostate cancer

Brachytherapy targeted to the peripheral zone with magnetic resonance imaging (MRI) guidance is a prostate cancer treatment option with potentially fewer complications than other treatments. Follow-up MRI when failure is suspected is, however, difficult because of radiation-induced changes. Furtherm...

Full description

Saved in:
Bibliographic Details
Published in:Urology (Ridgewood, N.J.) N.J.), 2005-12, Vol.66 (6), p.1319.e13-1319.e15
Main Authors: Szot Barnes, Agnieszka, Haker, Steven J., Mulkern, Robert V., So, Minna, D’Amico, Anthony V., Tempany, Clare M.
Format: Article
Language:English
Subjects:
Biopsy - methods
Brachytherapy - methods
Humans
Magnetic Resonance Imaging
Magnetic Resonance Spectroscopy
Male
Middle Aged
Neoplasm Recurrence, Local - pathology
Neoplasm Recurrence, Local - radiotherapy
Prostatic Neoplasms - pathology
Prostatic Neoplasms - radiotherapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c363t-a3367c6c9e99fae4e3e74f163229089d0ca24e6e160a868dc5832648543a3ca73
cites cdi_FETCH-LOGICAL-c363t-a3367c6c9e99fae4e3e74f163229089d0ca24e6e160a868dc5832648543a3ca73
container_end_page 1319.e15
container_issue 6
container_start_page 1319.e13
container_title Urology (Ridgewood, N.J.)
container_volume 66
creator Szot Barnes, Agnieszka
Haker, Steven J.
Mulkern, Robert V.
So, Minna
D’Amico, Anthony V.
Tempany, Clare M.
description Brachytherapy targeted to the peripheral zone with magnetic resonance imaging (MRI) guidance is a prostate cancer treatment option with potentially fewer complications than other treatments. Follow-up MRI when failure is suspected is, however, difficult because of radiation-induced changes. Furthermore, MR spectroscopy (MRS) is compromised by susceptibility artifacts from radioactive seeds in the peripheral zone. We report a case in which combined MRI/MRS was useful for the detection of prostate cancer in the transitional zone in patients previously treated with MR-guided brachytherapy. We propose that MRI/MRS can help detect recurrent prostate cancer, guide prostate biopsy, and help manage salvage treatment decisions.
doi_str_mv 10.1016/j.urology.2005.06.105
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68905124</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0090429505009180</els_id><sourcerecordid>68905124</sourcerecordid><originalsourceid>FETCH-LOGICAL-c363t-a3367c6c9e99fae4e3e74f163229089d0ca24e6e160a868dc5832648543a3ca73</originalsourceid><addsrcrecordid>eNqFkEFv1DAQhS1ERbeFnwDKiVuWSRxP4hNCFbRIRVzK2Zp1JluvsnGwHaT8e7zalXrsaaQ3b-bNfEJ8rGBbQYVfDtsl-NHv120NoLaAWVZvxKZSdVtqrdVbsQHQUDa1VtfiJsYDACBi-05cVygRGuw2Iv2i_cTJ2SJw9BNNlos4s03BR-vntdwvrue-SIGmrAc3MY3FnLuJEhc75-e4FjT1xS6QfV7TMwea12LwIW-0Swg8pRe_PQWE9-JqoDHyh0u9FX9-fH-6eygff9__vPv2WFqJMpUkJbYWrWatB-KGJbfNkG-vaw2d7sFS3TByhUAddr1Vnayx6VQjSVpq5a34fN6b8_8uHJM5umh5HGliv0SDnQZV1U02qrPR5kNj4MHMwR0prKYCc8JtDuaC25xwG8Asqzz36RKw7I7cv0xd-GbD17OB85v_HAcTrePMoHeZTjK9d69E_Ac7F5d8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68905124</pqid></control><display><type>article</type><title>Magnetic resonance spectroscopy-guided transperineal prostate biopsy and brachytherapy for recurrent prostate cancer</title><source>Elsevier</source><creator>Szot Barnes, Agnieszka ; Haker, Steven J. ; Mulkern, Robert V. ; So, Minna ; D’Amico, Anthony V. ; Tempany, Clare M.</creator><creatorcontrib>Szot Barnes, Agnieszka ; Haker, Steven J. ; Mulkern, Robert V. ; So, Minna ; D’Amico, Anthony V. ; Tempany, Clare M.</creatorcontrib><description>Brachytherapy targeted to the peripheral zone with magnetic resonance imaging (MRI) guidance is a prostate cancer treatment option with potentially fewer complications than other treatments. Follow-up MRI when failure is suspected is, however, difficult because of radiation-induced changes. Furthermore, MR spectroscopy (MRS) is compromised by susceptibility artifacts from radioactive seeds in the peripheral zone. We report a case in which combined MRI/MRS was useful for the detection of prostate cancer in the transitional zone in patients previously treated with MR-guided brachytherapy. We propose that MRI/MRS can help detect recurrent prostate cancer, guide prostate biopsy, and help manage salvage treatment decisions.</description><identifier>ISSN: 0090-4295</identifier><identifier>EISSN: 1527-9995</identifier><identifier>DOI: 10.1016/j.urology.2005.06.105</identifier><identifier>PMID: 16360468</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Biopsy - methods ; Brachytherapy - methods ; Humans ; Magnetic Resonance Imaging ; Magnetic Resonance Spectroscopy ; Male ; Middle Aged ; Neoplasm Recurrence, Local - pathology ; Neoplasm Recurrence, Local - radiotherapy ; Prostatic Neoplasms - pathology ; Prostatic Neoplasms - radiotherapy</subject><ispartof>Urology (Ridgewood, N.J.), 2005-12, Vol.66 (6), p.1319.e13-1319.e15</ispartof><rights>2005 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c363t-a3367c6c9e99fae4e3e74f163229089d0ca24e6e160a868dc5832648543a3ca73</citedby><cites>FETCH-LOGICAL-c363t-a3367c6c9e99fae4e3e74f163229089d0ca24e6e160a868dc5832648543a3ca73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16360468$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Szot Barnes, Agnieszka</creatorcontrib><creatorcontrib>Haker, Steven J.</creatorcontrib><creatorcontrib>Mulkern, Robert V.</creatorcontrib><creatorcontrib>So, Minna</creatorcontrib><creatorcontrib>D’Amico, Anthony V.</creatorcontrib><creatorcontrib>Tempany, Clare M.</creatorcontrib><title>Magnetic resonance spectroscopy-guided transperineal prostate biopsy and brachytherapy for recurrent prostate cancer</title><title>Urology (Ridgewood, N.J.)</title><addtitle>Urology</addtitle><description>Brachytherapy targeted to the peripheral zone with magnetic resonance imaging (MRI) guidance is a prostate cancer treatment option with potentially fewer complications than other treatments. Follow-up MRI when failure is suspected is, however, difficult because of radiation-induced changes. Furthermore, MR spectroscopy (MRS) is compromised by susceptibility artifacts from radioactive seeds in the peripheral zone. We report a case in which combined MRI/MRS was useful for the detection of prostate cancer in the transitional zone in patients previously treated with MR-guided brachytherapy. We propose that MRI/MRS can help detect recurrent prostate cancer, guide prostate biopsy, and help manage salvage treatment decisions.</description><subject>Biopsy - methods</subject><subject>Brachytherapy - methods</subject><subject>Humans</subject><subject>Magnetic Resonance Imaging</subject><subject>Magnetic Resonance Spectroscopy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neoplasm Recurrence, Local - pathology</subject><subject>Neoplasm Recurrence, Local - radiotherapy</subject><subject>Prostatic Neoplasms - pathology</subject><subject>Prostatic Neoplasms - radiotherapy</subject><issn>0090-4295</issn><issn>1527-9995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNqFkEFv1DAQhS1ERbeFnwDKiVuWSRxP4hNCFbRIRVzK2Zp1JluvsnGwHaT8e7zalXrsaaQ3b-bNfEJ8rGBbQYVfDtsl-NHv120NoLaAWVZvxKZSdVtqrdVbsQHQUDa1VtfiJsYDACBi-05cVygRGuw2Iv2i_cTJ2SJw9BNNlos4s03BR-vntdwvrue-SIGmrAc3MY3FnLuJEhc75-e4FjT1xS6QfV7TMwea12LwIW-0Swg8pRe_PQWE9-JqoDHyh0u9FX9-fH-6eygff9__vPv2WFqJMpUkJbYWrWatB-KGJbfNkG-vaw2d7sFS3TByhUAddr1Vnayx6VQjSVpq5a34fN6b8_8uHJM5umh5HGliv0SDnQZV1U02qrPR5kNj4MHMwR0prKYCc8JtDuaC25xwG8Asqzz36RKw7I7cv0xd-GbD17OB85v_HAcTrePMoHeZTjK9d69E_Ac7F5d8</recordid><startdate>20051201</startdate><enddate>20051201</enddate><creator>Szot Barnes, Agnieszka</creator><creator>Haker, Steven J.</creator><creator>Mulkern, Robert V.</creator><creator>So, Minna</creator><creator>D’Amico, Anthony V.</creator><creator>Tempany, Clare M.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20051201</creationdate><title>Magnetic resonance spectroscopy-guided transperineal prostate biopsy and brachytherapy for recurrent prostate cancer</title><author>Szot Barnes, Agnieszka ; Haker, Steven J. ; Mulkern, Robert V. ; So, Minna ; D’Amico, Anthony V. ; Tempany, Clare M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c363t-a3367c6c9e99fae4e3e74f163229089d0ca24e6e160a868dc5832648543a3ca73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Biopsy - methods</topic><topic>Brachytherapy - methods</topic><topic>Humans</topic><topic>Magnetic Resonance Imaging</topic><topic>Magnetic Resonance Spectroscopy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neoplasm Recurrence, Local - pathology</topic><topic>Neoplasm Recurrence, Local - radiotherapy</topic><topic>Prostatic Neoplasms - pathology</topic><topic>Prostatic Neoplasms - radiotherapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Szot Barnes, Agnieszka</creatorcontrib><creatorcontrib>Haker, Steven J.</creatorcontrib><creatorcontrib>Mulkern, Robert V.</creatorcontrib><creatorcontrib>So, Minna</creatorcontrib><creatorcontrib>D’Amico, Anthony V.</creatorcontrib><creatorcontrib>Tempany, Clare M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Urology (Ridgewood, N.J.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Szot Barnes, Agnieszka</au><au>Haker, Steven J.</au><au>Mulkern, Robert V.</au><au>So, Minna</au><au>D’Amico, Anthony V.</au><au>Tempany, Clare M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Magnetic resonance spectroscopy-guided transperineal prostate biopsy and brachytherapy for recurrent prostate cancer</atitle><jtitle>Urology (Ridgewood, N.J.)</jtitle><addtitle>Urology</addtitle><date>2005-12-01</date><risdate>2005</risdate><volume>66</volume><issue>6</issue><spage>1319.e13</spage><epage>1319.e15</epage><pages>1319.e13-1319.e15</pages><issn>0090-4295</issn><eissn>1527-9995</eissn><abstract>Brachytherapy targeted to the peripheral zone with magnetic resonance imaging (MRI) guidance is a prostate cancer treatment option with potentially fewer complications than other treatments. Follow-up MRI when failure is suspected is, however, difficult because of radiation-induced changes. Furthermore, MR spectroscopy (MRS) is compromised by susceptibility artifacts from radioactive seeds in the peripheral zone. We report a case in which combined MRI/MRS was useful for the detection of prostate cancer in the transitional zone in patients previously treated with MR-guided brachytherapy. We propose that MRI/MRS can help detect recurrent prostate cancer, guide prostate biopsy, and help manage salvage treatment decisions.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>16360468</pmid><doi>10.1016/j.urology.2005.06.105</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0090-4295
ispartof Urology (Ridgewood, N.J.), 2005-12, Vol.66 (6), p.1319.e13-1319.e15
issn 0090-4295
1527-9995
language eng
recordid cdi_proquest_miscellaneous_68905124
source Elsevier
subjects Biopsy - methods
Brachytherapy - methods
Humans
Magnetic Resonance Imaging
Magnetic Resonance Spectroscopy
Male
Middle Aged
Neoplasm Recurrence, Local - pathology
Neoplasm Recurrence, Local - radiotherapy
Prostatic Neoplasms - pathology
Prostatic Neoplasms - radiotherapy
title Magnetic resonance spectroscopy-guided transperineal prostate biopsy and brachytherapy for recurrent prostate cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T12%3A05%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Magnetic%20resonance%20spectroscopy-guided%20transperineal%20prostate%20biopsy%20and%20brachytherapy%20for%20recurrent%20prostate%20cancer&rft.jtitle=Urology%20(Ridgewood,%20N.J.)&rft.au=Szot%20Barnes,%20Agnieszka&rft.date=2005-12-01&rft.volume=66&rft.issue=6&rft.spage=1319.e13&rft.epage=1319.e15&rft.pages=1319.e13-1319.e15&rft.issn=0090-4295&rft.eissn=1527-9995&rft_id=info:doi/10.1016/j.urology.2005.06.105&rft_dat=%3Cproquest_cross%3E68905124%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c363t-a3367c6c9e99fae4e3e74f163229089d0ca24e6e160a868dc5832648543a3ca73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=68905124&rft_id=info:pmid/16360468&rfr_iscdi=true